Company profile

Q Bio, Inc.

Q Bio, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on September 12, 2024 and the most recent on September 12, 2024 (Constellation (CON-001)). Its most common review panel is Radiology (1 device).

1AI devices
2024First decision
2024Latest decision
1Specialties

Timeline

  1. Constellation (CON-001) · Radiology · QIH